Metformin and the risk of dementia based on an analysis of 396,332 participants

• Hlavní autoři: Shiliang Ji (Autor), Xingxing Zhao (Autor), Ruifang Zhu (Autor), Yongchao Dong (Autor), Lifeng Huang (Autor), Taiquan Zhang (Autor)
• Médium: Kniha
• Vydáno: SAGE Publishing, 2022-07-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

Background: AMPK has attracted widespread interest as a potential therapeutic target for age-related diseases, given its key role in controlling energy homeostasis. Metformin (Met) has historically been used to treat Type 2 diabetes and has been shown to counteract age-related diseases. However, stu...